Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

An image of the COVID vaccine.

To Increase Vaccine Manufacturing in LMICs, We Also Need to Strengthen Regulatory Capacity

A lot of recent discussions focus on how to expand COVID-19 vaccine manufacturing capacity in low- and middle-income countries (LMICs). The conversations highlight the importance of technology transfer and the capability of the tech transfer receiving sites (the facilities in these countries that would then produce vaccines locally), including having specialized equipment and personnel.

Figure 1. Comparison of per patient consumption of oxygen for oxygen therapy versus ventilators

More than Oxygen Supply: How to Make the Current Global Fund COVID-19 Response Mechanism a Success for Patients

The global COVID-19 pandemic has highlighted the pressing need to improve oxygen supplies around the world. In this blog, we highlight key objectives that countries need to consider in their funding applications for support from the CRM for the successful scale up of oxygen and critical care.

A gloved hand holds a COVID-19 vaccine vial in front of a blue background

Dear President Biden and Congress: Time for US to Lead Response to the Growing COVID-19 Global Vaccine Crisis

Today we joined colleagues from CSIS, Duke University, and the COVID Collective in an open letter to the Biden Administration and US Congress with a clear message: to hasten the end of the COVID-19 global pandemic, American leadership is required to ensure universal global access to high-quality and safe vaccines, support rapid vaccine distribution and administration, and build a sustainable global network of vaccine manufacturing capacity. Vaccines offer an exit route out of the pandemic – but only if they reach a critical mass of people in need across continents, socioeconomic strata, and marginalized populations.

An image of a woman receiving a COVID vaccine.

A Matter of Trust and Coordination: A COVID-19 Vaccination Certificate for Southeast Asia?

As governments worldwide increase their COVID-19 vaccination coverage, COVID-19 vaccination certificates (CVCs) are making headlines as a possible answer to the question of how to reopen economies safely. While countries like Israel and Estonia are well advanced in introducing CVCs, developing countries, as with their vaccination rates, are further behind. In especially interconnected developing regions like Southeast Asia, CVCs present unprecedented collaboration challenges, including that of coordination and trust.

Pages